In-Depth Analysis of Commercial Media Used for Serial Expansion of Human Induced Pluripotent Stem Cells in Suspension Bioreactor Systems

This publication examines critical upstream manufacturing challenges associated with scaling pluripotent stem cell cultures for commercial allogeneic cell therapy production. The paper evaluates key process variables including seed train generation, hydrodynamic conditions, aggregate morphology control, oxygen transfer, carbon dioxide removal, medium exchange, and cell harvest operations. Computational fluid dynamics and experimental studies demonstrate how energy dissipation rate can be used as a predictive scale-up parameter to maintain uniform aggregate morphology across bioreactor scales. The authors also propose strategies for oxygenation and scalable media exchange that minimize process bottlenecks for sensitive aggregate cultures. The article provides practical engineering frameworks for developing robust large-scale manufacturing processes while maintaining pluripotency and therapeutic cell quality.